https://ephrinreceptor.com/ind....ex.php/rendering-reg
A primary neuroprotective mechanism of metformin is the activation of adenosine monophosphate-activated protein kinase (AMPK), which reduces mitochondrial dysfunction, oxidative stress, and alpha-synuclein aggregation. Similarly, metformin reduces inflammation within the brain, a primary sign of Parkinson's disease and other neurological conditions. The potential negative effect of metformin on P
Like
Comment
Share
